title: CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.
abstract: Crk-like (CrkL) is an adapter protein that has crucial roles in cell proliferation, adhesion, and migration. However, the expression pattern and potential mechanism of CrkL protein in glioblastoma multiforme (GBM) have not been fully elucidated. To determine roles of CrkL in cell signaling, proliferation, and migration, small interfering RNAs and plasmids transfection were used to suppress or overexpress CrkL in U87 and U251; soft-agar assay and wound-healing assay were used to observe cell invasiveness, migration, and proliferation. Erk1/2, Smad2, and matrix metalloproteinase 9 (MMP9) were also analyzed by western blot. CrkL was expressed in U87 and U251 cell lines and can be activated by transforming growth factor-beta 1 (TGF-β1) in vitro; CrkL knockdown significantly suppressed the expression of phosph-ERK1/2 and MMP9 but enhanced phosph-Smad2 expression compared with control (p <0.001). Overexpression of CrkL against control upregulated phosph-ERK1/2 and MMP9 and, at the same time, downregulated phosph-Smad2 (p <0.01). On the other hand, CrkL knockdown could significantly affect U87 and U251 invasiveness (p <0.01) and wound closure (p <0.01) using soft-agar assay and wound-healing assay. These studies suggest that CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma. Furthermore, CrkL can be used as a potential and efficient therapeutic target of GBM and may also mediate other signaling pathway.
authors: Shunzeng
authors: S
authors: Lv
authors: Juan
authors: J
authors: Qin
authors: Ruiyang
authors: R
authors: Yi
authors: Melody
authors: M
authors: Coreman
authors: Ranran
authors: R
authors: Shi
authors: Huihui
authors: H
authors: Kang
authors: Chengjun
authors: C
authors: Yao
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002465:Cell Movement; D049109:Cell Proliferation; D005909:Glioblastoma / Q000378:metabolism*; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism; D019950:Mitogen-Activated Protein Kinase 1 / Q000235:genetics / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000235:genetics / Q000378:metabolism; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D051899:Smad2 Protein / Q000235:genetics / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C082869:CRKL protein; D009687:Nuclear Proteins; D051899:Smad2 Protein; D016212:Transforming Growth Factor beta; C535150:MAPK1 protein, human; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; C579270:MMP9 protein, human; D020780:Matrix Metalloproteinase 9
references: Genes Dev. 2005 Dec 1;19(23):2783-810
references: 16322555
references: Biochem Pharmacol. 2013 Feb 15;85(4):478-85
references: 23159669
references: Curr Pharm Des. 2006;12(3):341-9
references: 16454748
references: Cell. 2003 Jun 13;113(6):685-700
references: 12809600
references: Int J Cancer. 1995 Aug 9;62(4):386-92
references: 7635563
references: Genes Cancer. 2012 May;3(5-6):341-52
references: 23226572
references: Int J Cancer. 2000 May 20;89(3):251-8
references: 10861501
references: Oncogene. 2001 Oct 1;20(44):6348-71
references: 11607838
references: Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):23-35
references: 10708950
references: Clin Neurosurg. 2006;53:106-13
references: 17380744
references: Blood. 1994 Sep 15;84(6):1731-6
references: 7521685
references: J Cell Biol. 2011 Jan 24;192(2):209-18
references: 21263025
references: FEBS Lett. 2010 Jan 4;584(1):7-14
references: 19883646
references: Nature. 2004 Jul 8;430(6996):226-31
references: 15241418
references: Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9671-6
references: 15210957
references: Nature. 2002 Jan 31;415(6871):530-6
references: 11823860
references: Cancer Metastasis Rev. 2003 Dec;22(4):395-403
references: 12884914
references: Cell Res. 2009 Jan;19(1):36-46
references: 19114992
references: Acta Biochim Pol. 2005;52(2):329-37
references: 15990918
references: Oncogene. 1993 Sep;8(9):2469-74
references: 8361759
references: Cell Signal. 2006 Dec;18(12):2162-71
references: 16781119
references: Exp Hematol. 2012 Dec;40(12):1055-9
references: 22960265
references: N Engl J Med. 2008 Jul 31;359(5):492-507
references: 18669428
references: Oncogene. 2002 Aug 15;21(36):5601-8
references: 12165859
references: Genes Cancer. 2010 Nov;1(11):1132-9
references: 21779437
references: J Cell Biochem. 2005 Aug 1;95(5):918-31
references: 15861394
references: Int J Cancer. 1999 Mar 1;80(5):756-63
references: 10048979
references: J Transl Med. 2012 Jul 03;10:97
references: 22591714
references: EMBO J. 2004 Apr 21;23(8):1770-81
references: 15057277
references: J Neurooncol. 2001 Jun;53(2):177-85
references: 11716069
references: Cell Commun Signal. 2009 May 10;7:13
references: 19426560